Novo will test Claude Science on specific drug discovery workflows
Novo Nordisk, which now trades day to day as Novo, announced a collaboration with Anthropic on 16 September 2026. It will test Claude Science on specific research and development workflows, on top of the Claude system that already writes its regulatory documents.








































